Therapy of chemotherapy-induced peripheral neuropathy

British Journal of Haematology

Volumn 145, Issue 1, 2009, Pages 3-14

  Kaley, Thomas J ^a   Deangelis, Lisa M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Chemotherapy induced peripheral neuropathy; Neuropathy treatment; Peripheral neuropathy

Indexed keywords

ALPHA TOCOPHEROL; ALTRETAMINE; AMIFOSTINE; ANTINEOPLASTIC AGENT; AZACITIDINE; BORTEZOMIB; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; ETOPOSIDE; FLUDARABINE; GLUCONATE CALCIUM; GLUTATHIONE; MAGNESIUM SULFATE; MISONIDAZOLE; MITOTANE; NONSTEROID ANTIINFLAMMATORY AGENT; OXALIPLATIN; PACLITAXEL; PLACEBO; PLATINUM DERIVATIVE; PROCARBAZINE; SURAMIN; TAXANE DERIVATIVE; TENIPOSIDE; THALIDOMIDE; UNINDEXED DRUG; VINCA ALKALOID; VINCRISTINE;

ACUPUNCTURE; ARTICLE; AUTONOMIC NEUROPATHY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL EVALUATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CRANIAL NEUROPATHY; DIABETIC NEUROPATHY; DISEASE CLASSIFICATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NEUROPATHIC PAIN; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROPHYLAXIS; SENSORIMOTOR NEUROPATHY; SENSORY NEUROPATHY; VITAMIN SUPPLEMENTATION;

ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 61849097298     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07558.x     Document Type: Article

References (80)

1. Argyriou, A.A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G. Kalofonos, H.P. (2005) Vitamin E for prophylaxis against chemotherapy-induced neuropathy. Neurology, 64, 26 31.
2. Argyriou, A.A., Chroni, E., Koutras, A., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P. Kalofonos, H.P. (2006a) Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. Journal of Pain & Symptom Management, 32, 237 244.
3. Argyriou, A.A., Chroni, E., Koutras, A., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P. Kalofonos, H.P. (2006b) A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Supportive Care in Cancer, 14, 1134 1140.
4. Argyriou, A.A., Chroni, E., Polychronopoulos, P., Iconomou, G., Koutras, A., Makatsoris, T., Gerolymos, M.K., Gourzis, P., Assimakopoulos, K. Kalofonos, H.P. (2006c) Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. Neurology, 67, 2253 2255.
5. Argyriou, A.A., Polychronopoulos, P., Iconomou, G., Chroni, E. Kalofonos, H.P. (2008) A review on oxaliplatin-induced peripheral nerve damage. Cancer Treatment Reviews, 34, 368 377.
6. Backonja, M., Beydoun, A., Edwards, K.R., Schwartz, S.L., Fonseca, V., Hes, M., LaMoreaux, L. Garofalo, E. (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial (see comment). Journal of the American Medical Association, 280, 1831 1836.
7. Badros, A., Goloubeva, O., Fenton, R., Rapoport, A.P., Akpek, G., Harris, C., Ruehle, K., Westphal, S. Meisenberg, B. (2006) Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma. Clinical Lymphoma & Myeloma, 7, 210 216.
8. van den Bent, M.J. (2005) Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor (comment). Clinical Cancer Research, 11, 1691 1693.
9. Bianchi, G., Vitali, G., Caraceni, A., Ravaglia, S., Capri, G., Cundari, S., Zanna, C. Gianni, L. (2005) Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. European Journal of Cancer, 41, 1746 1750.
10. Callizot, N., Andriambeloson, E., Glass, J., Revel, M., Ferro, P., Cirillo, R., Vitte, P.-A. Dreano, M. (2008) Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity. Cancer Chemotherapy and Pharmacology, 62, 995 1007.
11. Caraceni, A., Zecca, E., Bonezzi, C., Arcuri, E., Yaya Tur, R., Maltoni, M., Visentin, M., Gorni, G., Martini, C., Tirelli, W., Barbieri, M. De Conno, F. (2004) Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group (see comment). Journal of Clinical Oncology, 22, 2909 2917.
12. Carrazana, E. Mikoshiba, I. (2003) Rationale and evidence for the use of oxcarbazepine in neuropathic pain. Journal of Pain & Symptom Management, 25, S31 S35.
13. Cascinu, S., Cordella, L., Del Ferro, E., Fronzoni, M. Catalano, G. (1995) Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. Journal of Clinical Oncology, 13, 26 32.
14. Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A.M., Beretta, G.D., Ubiali, E. Catalano, G. (2002) Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology, 20, 3478 3483.
15. Cata, J.P., Cordella, J.V., Burton, A.W., Hassenbusch, S.J., Weng, H.R. Dougherty, P.M. (2004) Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report. Journal of Pain & Symptom Management, 27, 72 78.
16. Cohen, K.L. Harris, S. (1987) Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Archives of Internal Medicine, 147, 1442 1444.
17. Collins, S.L., Moore, R.A., McQuay, H.J. Wiffen, P. (2000) Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. Journal of Pain & Symptom Management, 20, 449 458.
18. Cruccu, G. (2007) Treatment of painful neuropathy. Current Opinion in Neurology, 20, 531 535.
19. Davis, I.D., Kiers, L., MacGregor, L., Quinn, M., Arezzo, J., Green, M., Rosenthal, M., Chia, M., Michael, M., Bartley, P., Harrison, L. Daly, M. (2005) A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy (see comment). Clinical Cancer Research, 11, 1890 1898.
20. De Santis, S., Pace, A., Bove, L., Cognetti, F., Properzi, F., Fiore, M., Triaca, V., Savarese, A., Simone, M.D., Jandolo, B., Manzione, L. Aloe, L. (2000) Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor. Clinical Cancer Research, 6, 90 95.
21. DeAngelis, L.M. Posner, J.B. (2008) Neurologic Complications of Cancer. Oxford University Press, New York.
22. DeAngelis, L.M., Gnecco, C., Taylor, L. Warrell, R.P. Jr. (1991) Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin's lymphoma. Cancer, 67, 2241 2246.
23. Delius, S.v., Eckel, F., Wagenpfeil, S., Mayr, M., Stock, K., Kullmann, F., Obermeier, F., Erdmann, J., Schmelz, R., Quasthoff, S., Adelsberger, H., Bredenkamp, R., Schmid, R.M. Lersch, C. (2007) Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study. Investigational New Drugs, 25, 173 180.
24. Dellon, A.L., Swier, P., Maloney, C.T., Livengood, M.S. Werter, S. (2004) Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves. Plastic and Reconstructive Surgery, 114, 478 483.
25. Dougherty, P.M., Cata, J.P., Burton, A.W., Vu, K. Weng, H.R. (2007) Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. Journal of Pain & Symptom Management, 33, 166 179.
26. Durand, J.P., Brezault, C. Goldwasser, F. (2003) Protection against oxaliplatin acute neurosensory toxicity by venlafaxine. Anti-Cancer Drugs, 14, 423 425.
27. Durand, J.P., Alexandre, J., Guillevin, L. Goldwasser, F. (2005) Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy. Anti-Cancer Drugs, 16, 587 591.
28. Eckhardt, K., Ammon, S., Hofmann, U., Riebe, A., Gugeler, N. Mikus, G. (2000) Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesthesia and Analgesia, 91, 185 191.
29. Eisenberg, E., Lurie, Y., Braker, C., Daoud, D. Ishay, A. (2001) Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology, 57, 505 509.
30. Ertas, M., Sagduyu, A., Arac, N., Uludag, B. Ertekin, C. (1998) Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain, 75, 257 259.
31. Flatters, S.J., Xiao, W.H. Bennett, G.J. (2006) Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neuroscience Letters, 397, 219 223.
32. Forsyth, P.A., Balmaceda, C., Peterson, K., Seidman, A.D., Brasher, P. DeAngelis, L.M. (1997) Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. Journal of Neuro-Oncology, 35, 47 53.
33. Gamelin, L., Boisdron-Celle, M., Delva, R., Guerin-Meyer, V., Ifrah, N., Morel, A. Gamelin, E. (2004) Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clinical Cancer Research, 10, 4055 4061.
34. Gedlicka, C., Scheithauer, W., Schull, B. Kornek, G.V. (2002) Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid. Journal of Clinical Oncology, 20, 3359 3361.
35. Gedlicka, C., Kornek, G.V., Schmid, K. Scheithauer, W. (2003) Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid. Annals of Oncology, 14, 339 340.
36. Gilron, I. Bailey, J.M. (2003) Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials (see comment). Canadian Journal of Anaesthesia, 50, 42 47.
37. Halat, K.M. Dennehy, C.E. (2003) Botanicals and dietary supplements in diabetic peripheral neuropathy. Journal of the American Board of Family Practice, 16, 47 57.
38. Hammack, J.E., Michalak, J.C., Loprinzi, C.L., Sloan, J.A., Novotny, P.J., Soori, G.S., Tirona, M.T. Jr., Rowland, K.M. Jr., Stella, P.J. Johnson, J.A. (2002) Phase III evaluation of nortriptyline for alleviation of symptoms of cisplatinum-induced peripheral neuropathy. Pain, 98, 195 203.
39. Hildebrand, J. (2006) Neurological complications of cancer chemotherapy. Current Opinion in Oncology, 18, 321 324.
40. Hochster, H.S., Grothey, A. Childs, B.H. (2007) Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. Journal of Clinical Oncology, 25, 4028 4029.
41. Kannarkat, G., Lasher, E.E. Schiff, D. (2007) Neurologic complications of chemotherapy agents. Current Opinion in Neurology, 20, 719 725.
42. Kautio, A.L., Haanpaa, M., Saarto, T. Kalso, E. (2008) Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. Journal of Pain & Symptom Management, 35, 31 39.
43. Kemp, G., Rose, P., Lurain, J., Berman, M., Manetta, A., Roullet, B., Homesley, H., Belpomme, D. Glick, J. (1996) Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. Journal of Clinical Oncology, 14, 2101 2112.
44. Kochar, D.K., Rawat, N., Agrawal, R.P., Vyas, A., Beniwal, R., Kochar, S.K. Garg, P. (2004) Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM, 97, 33 38.
45. Lin, P.C., Lee, M.Y., Wang, W.S., Yen, C.C., Chao, T.C., Hsiao, L.T., Yang, M.H., Chen, P.M., Lin, K.P. Chiou, T.J. (2006) N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Supportive Care in Cancer, 14, 484 487.
46. Low, P.A., Opfer-Gehrking, T.L., Dyck, P.J., Litchy, W.J. O'Brien, P.C. (1995) Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain, 62, 163 168.
47. McCleane, G. (1999) 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. Pain, 83, 105 107.
48. Mollman, J.E., Glover, D.J., Hogan, W.M. Furman, R.E. (1988) Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721. Cancer, 61, 2192 2195.
49. Moore, D.H., Donnelly, J., McGuire, W.P., Almadrones, L., Cella, D.F., Herzog, T.J., Waggoner, S.E. for the Gynecologic Oncology Group 2003) Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group. Journal of Clinical Oncology, 21, 4207 4213.
50. Ocean, A.J. Vahdat, L.T. (2004) Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Supportive Care in Cancer, 12, 619 625.
51. Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F. Bove, L. (2003) Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. Journal of Clinical Oncology, 21, 927 931.
52. Park, S.A., Choi, K.S., Bang, J.H., Huh, K. Kim, S.U. (2000) Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. Journal of Neurochemistry, 75, 946 953.
53. Pisano, C., Pratesi, G., Laccabue, D., Zunino, F., Lo Giudice, P., Bellucci, A., Pacifici, L., Camerini, B., Vesci, L., Castorina, M., Cicuzza, S., Tredici, G., Marmiroli, P., Nicolini, G., Galbiati, S., Calvani, M., Carminati, P. Cavaletti, G. (2003) Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clinical Cancer Research, 9, 5756 5767.
54. Plasmati, R., Pastorelli, F., Cavo, M., Petracci, E., Zamagni, E., Tosi, P., Cangini, D., Tacchetti, P., Salvi, F., Bartolomei, I., Michelucci, R. Tassinari, C.A. (2007) Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Neurology, 69, 573 581.
55. Postma, T.J. Heimans, J.J. (2000) Grading of chemotherapy-induced peripheral neuropathy. Annals of Oncology, 11, 509 513.
56. Price, M.J. (2004) Levetiracetam in the treatment of neuropathic pain: three case studies. Clinical Journal of Pain, 20, 33 36.
57. Rao, R.D., Michalak, J.C., Sloan, J.A., Loprinzi, C.L., Soori, G.S., Nikcevich, D.A., Warner, D.O., Novotny, P., Kutteh, L.A. Wong, G.Y. (2007) Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer, 110, 2110 2118.
58. Rao, R.D., Flynn, P.J., Sloan, J.A., Wong, G.Y., Novotny, P., Johnson, D.B., Gross, H.M., Renno, S.I., Nashawaty, M. Loprinzi, C.L. (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer, 112, 2802 2808.
59. Raskin, P., Donofrio, P.D., Rosenthal, N.R., Hewitt, D.J., Jordan, D.M., Xiang, J. Vinik, A.I. (2004) Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology, 63, 865 873.
60. Richardson, P.G., Briemberg, H., Jagannath, S., Wen, P.Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D.S., Irwin, D., Schuster, M., Srkalovic, G., Alexanian, R., Rajkumar, S.V., Limentani, S., Alsina, M., Orlowski, R.Z., Najarian, K., Esseltine, D., Anderson, K.C. Amato, A.A. (2006) Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. Journal of Clinical Oncology, 24, 3113 3120.
61. Rodriguez-Menendez, V., Tremolizzo, L. Cavaletti, G. (2008) Targeting cancer and neuropathy with histone deacetylase inhibitors: two birds with one stone? Curr Cancer Drug Targets, 8, 266 274.
62. Rosenstock, J., Tuchman, M., LaMoreaux, L. Sharma, U. (2004) Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain, 110, 628 638.
63. Ross, J.R., Goller, K., Hardy, J., Riley, J., Broadley, K., A'Hern, R. Williams, J. (2005) Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study. Journal of Palliative Medicine, 8, 1118 1126.
64. Rowbotham, M.C., Goli, V., Kunz, N.R. Lei, D. (2004) Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study [erratum in Pain 2005, 113(1-2), 248]. Pain, 110, 697 706.
65. Savarese, D.M., Savy, G., Vahdat, L., Wischmeyer, P.E. Corey, B. (2003) Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treatment Reviews, 29, 501 513.
66. Scott, K., Zeris, S. Kothari, M.J. (2008) Elevated B6 levels and peripheral neuropathies. Electromyography and Clinical Neurophysiology, 48, 219 223.
67. Silver, M., Blum, D., Grainger, J., Hammer, A.E. Quessy, S. (2007) Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. Journal of Pain & Symptom Management, 34, 446 454.
68. Simpson, D.M., Olney, R., McArthur, J.C., Khan, A., Godbold, J. Ebel-Frommer, K. (2000) A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology, 54, 2115 2119.
69. Sindrup, S.H., Andersen, G., Madsen, C., Smith, T., Brosen, K. Jensen, T.S. (1999) Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain, 83, 85 90.
70. Spina, E. Perugi, G. (2004) Antiepileptic drugs: indications other than epilepsy. Epileptic Disorders, 6, 57 75.
71. Stone, K.J., Viera, A.J. Parman, C.L. (2003) Off-label applications for SSRIs (see comment). American Family Physician, 68, 498 504.
72. Vahdat, L., Papadopoulos, K., Lange, D., Leuin, S., Kaufman, E., Donovan, D., Frederick, D., Bagiella, E., Tiersten, A., Nichols, G., Garrett, T., Savage, D., Antman, K., Hesdorffer, C.S. Balmaceda, C. (2001) Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clinical Cancer Research, 7, 1192 1197.
73. Walker, M. Ni, O. (2007) Neuroprotection during chemotherapy: a systematic review. American Journal of Clinical Oncology, 30, 82 92.
74. Watson, C.P., Moulin, D., Watt-Watson, J., Gordon, A. Eisenhoffer, J. (2003) Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain, 105, 71 78.
75. Wen, P.Y. (2005) A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy (comment). Clinical Cancer Research, 11, 1685 1686.
76. Wilkes, G. (2007) Peripheral neuropathy related to chemotherapy. Seminars in Oncology Nursing, 23, 162 173.
77. Windebank, A.J. (1999) Chemotherapeutic neuropathy. Current Opinion in Neurology, 12, 565 571.
78. Wolfe, G.I. Trivedi, J.R. (2004) Painful peripheral neuropathy and its nonsurgical treatment. Muscle and Nerve, 30, 3 19.
79. Wong, R. Sagar, S. (2006) Acupuncture treatment for chemotherapy-induced peripheral neuropathy - a case series. Acupuncture in Medicine, 24, 87 91.
80. Xiao, W.H. Bennett, G.J. (2008) Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine. Pain, 135, 262 270.